Parstatin (human) is a peptide derived from the N-terminal region of the protease-activated receptor 1 (PAR1). It has been studied for its potential therapeutic applications, particularly in the context of angiogenesis and inflammation. Research suggests that Parstatin may inhibit the formation of new blood vessels, making it a candidate for anti-angiogenic therapy in diseases like cancer, where uncontrolled blood vessel growth supports tumor progression. Additionally, its anti-inflammatory properties have been explored in conditions such as myocardial infarction, where it may help reduce tissue damage and improve recovery. Further studies are ongoing to fully understand its mechanisms and potential clinical uses.